Castle Biosciences, Inc.

CSTL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1$5-$26$10
Dep. & Amort.$4$3$30$6
Deferred Tax$0-$5-$1-$2
Stock-Based Comp.$0$11$11$11
Change in WC$12$9-$20$2
Other Non-Cash$8-$2$0-$2
Operating Cash Flow$23$21-$6$24
Investing Activities
PP&E Inv.-$15-$9-$5-$8
Net Acquisitions$0-$19$0$0
Inv. Purchases-$58-$44-$48-$47
Inv. Sales/Matur.$55$44$36$61
Other Inv. Act.$0$0-$6$0
Investing Cash Flow-$18-$28-$22$6
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$0-$2-$6
Financing Cash Flow-$1$0-$2-$5
Forex Effect$0$0$0$0
Net Chg. in Cash$3-$7-$30$25
Supplemental Information
Beg. Cash$82$90$120$95
End Cash$86$82$90$120
Free Cash Flow$8$12-$11$17
Castle Biosciences, Inc. (CSTL) Financial Statements & Key Stats | AlphaPilot